← Open Payments lookup

WILLIAM BURSTEIN: Open Payments

NPI 1376582510 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,167 in 87 payments from 20 companies in 2025. Trend: 2023 $1,590 · 2024 $1,706 · 2025 $2,167

Food & beverage: $2,167
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$289
Amgen Inc.11$238
Teva Pharmaceuticals USA, Inc.12$227
Novo Nordisk Inc11$226
ABBVIE INC.8$211
Otsuka America Pharmaceutical, Inc.3$165
Phathom Pharmaceuticals, Inc.2$133
Lilly USA, LLC5$100
GlaxoSmithKline, LLC.5$91
PFIZER INC.4$67

Products named: AIRSUPRA, AUSTEDO XR, REXULTI, UBRELVY, VOQUEZNA, Ozempic, REPATHA, MOUNJARO.

Industry payments across PA — which companies pay providers there.